Austin Regional Clinic (ARC), a leading multispecialty medical group serving the Central Texas community since 1980, has proudly announced its partnership with Innovo Research, a provider-sponsored, provider-led network of high-performing medical organizations focused on innovative clinical research strategies.
By joining forces with Innovo Research, ARC aims to enhance its commitment to providing Central Texas with access to advanced medical treatment by integrating cutting-edge research methodologies into patient care. ARC first opened its clinical research department at the end of 2016 and was a major study center for COVID-19 vaccines in 2020 and 2021. This partnership enables ARC to collaborate with a network of like-minded organizations and continue to play a role in advancing science and medicine, while benefiting individuals in local communities.
Anas Daghestani, MD, ARC President & CEO, expressed enthusiasm about this collaboration, stating, “We believe that by combining our decades of expertise in patient care with the experience of Innovo Research in innovative and rigorous clinical research, we can continue to enhance ARC’s healthcare model that truly prioritizes patient outcomes and community well-being.”
Jeff James, CEO of Innovo Research, echoed this sentiment, saying, “We are thrilled to welcome Austin Regional Clinic into the Innovo family. Their dedication to patient-centric and high-quality care aligns perfectly with our mission, and we are confident that together, we will advance these goals.”
The partnership signifies a meaningful next step in the evolution of health care, where research and patient care converge to create a more efficient, accessible, and patient-focused approach. For more information about this collaboration and the services offered by ARC and Innovo Research, please visit ARC Clinical Research and Innovo Research.
ARC is a multispecialty medical group committed to providing easy access to high quality, comprehensive healthcare services throughout Central Texas. ARC provides health care to over 630,000 area residents in 35 clinics in 15 Central Texas cities, including both primary and specialty care. ARC Clinical Research opened in November, 2016, and since then ARC has been involved in over 50 clinical studies.
About Innovo Research
Innovo Research, under the leadership of CEO Jeff James, is a pioneer in integrating clinical research into population health strategies. Their provider-sponsored approach fosters collaboration among healthcare professionals, researchers, and patients, leading to superior patient outcomes, reduced industry costs, and increased patient engagement. Innovo Research’s expertise lies in optimizing patient access to clinical trials, enhancing efficiency, and accelerating enrollment processes, resulting in a more streamlined and effective healthcare system.